Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will ...
JAMP Pharma Group launches PrPexegra®, a biosimilar alternative to the reference product PrNeulasta® (commercialized in ...
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback